2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|---|
营业收入(元) | |||||
合同研发生产服务(元) | - | - | - | - | 921,144,358.77 |
原料药、中间体(元) | 4,704,422,720.91 | 7,987,061,899.85 | 4,204,414,658.10 | 7,736,937,257.72 | 3,548,092,685.55 |
制剂(元) | 679,555,972.19 | 1,249,222,531.40 | 574,079,137.76 | 1,079,756,508.23 | 487,354,051.69 |
创新药研发生产服务(元) | 1,027,537,535.96 | 2,004,981,793.08 | 1,139,433,010.96 | 1,577,470,850.85 | - |
其他(元) | - | 198,973,429.45 | - | 111,638,318.94 | - |
营业成本(元) | |||||
合同研发生产服务(元) | - | - | - | - | 542,762,728.45 |
原料药、中间体(元) | 3,941,420,000.51 | 6,584,450,067.93 | 3,425,916,363.29 | 6,445,805,959.46 | 2,932,027,686.04 |
制剂(元) | 269,812,695.57 | 585,399,391.02 | 284,855,612.40 | 516,913,940.65 | 238,721,694.44 |
创新药研发生产服务(元) | 615,605,748.01 | 1,157,075,250.99 | 629,298,288.07 | 930,425,631.62 | - |
其他(元) | - | 184,586,757.44 | - | 103,210,976.19 | - |
毛利(元) | |||||
合同研发生产服务(元) | - | - | - | - | 378,381,630.32 |
原料药、中间体(元) | 763,002,720.40 | 1,402,611,831.92 | 778,498,294.81 | 1,291,131,298.26 | 616,064,999.51 |
制剂(元) | 409,743,276.62 | 663,823,140.38 | 289,223,525.36 | 562,842,567.58 | 248,632,357.25 |
创新药研发生产服务(元) | 411,931,787.95 | 847,906,542.09 | 510,134,722.89 | 647,045,219.23 | - |
其他(元) | - | 14,386,672.01 | - | 8,427,342.75 | - |
毛利率(%) | |||||
合同研发生产服务(%) | - | - | - | - | 41.08 |
原料药、中间体(%) | 16.22 | 17.56 | 18.52 | 16.69 | 17.36 |
制剂(%) | 60.30 | 53.14 | 50.38 | 52.13 | 51.02 |
创新药研发生产服务(%) | 40.09 | 42.29 | 44.77 | 41.02 | - |
其他(%) | - | 7.23 | - | 7.55 | - |
收入构成(%) | |||||
合同研发生产服务(%) | - | - | - | - | 18.58 |
原料药、中间体(%) | 73.37 | 69.82 | 71.05 | 73.64 | 71.58 |
制剂(%) | 10.60 | 10.92 | 9.70 | 10.28 | 9.83 |
创新药研发生产服务(%) | 16.03 | 17.53 | 19.25 | 15.02 | - |
其他(%) | - | 1.74 | - | 1.06 | - |
毛利构成(%) | |||||
合同研发生产服务(%) | - | - | - | - | 30.44 |
原料药、中间体(%) | 48.15 | 47.89 | 49.34 | 51.45 | 49.56 |
制剂(%) | 25.86 | 22.67 | 18.33 | 22.43 | 20.00 |
创新药研发生产服务(%) | 25.99 | 28.95 | 32.33 | 25.78 | - |
其他(%) | - | 0.49 | - | 0.34 | - |